Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 1 Trials for Vincristine (DB00541)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003166Bryostatin and Vincristine in B-Cell MalignanciesTreatment